Intersect ENT, Inc. products

The Cube 4D system – the next dimension navigation system. The Cube 4D system provides electromagnetic guidance that’s intuitive and simply precise. It’s a top-of-the-line virtual guidance platform that helps optimize ENT and ENT-related skull-base surgeries. It delivers precise image guidance, incorporating novel, touchless Photo Registration technology. The modular platform integrates seamlessly into existing video towers for support of minimally invasive ENT procedures.

SINUVA is the first and only FDA-approved stent for the treatment of nasal polyps in adult patients 18 years or older who have had ethmoid sinus surgery Are you still living with nasal polyps? Consider an alternative to another sinus surgery — SINUVA is a nonsurgical treatment option that can be placed in office. SINUVA delivers anti-inflammatory medicine directly to the nasal polyps, providing up to 90 days of continuous relief. Once it’s in place, it usually can’t be felt—and you don’t need to remember to take SINUVA daily. SINUVA is designed to stay in your ethmoid sinus until your doctor removes it 90 days after placement or sooner.

VenSure balloon sinus dilation means simplicity with optimized results. Simplify your procedure with VenSure, an elegant balloon dilation system designed to redefine the standard of ENT care.

The PROPEL sinus implants are indicated to maintain patency and locally deliver steroid to the sinus mucosa in patients ≥18 years of age after sinus surgery: PROPEL for the ethmoid sinus, PROPEL Mini for the ethmoid sinus/frontal sinus opening, and PROPEL Contour for the frontal/maxillary sinus ostia. Contraindications include patients with intolerance to mometasone furoate (MF) or hypersensitivity to bioabsorbable polymers. Safety and effectiveness of the implant in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/pressure, displacement of the implant, possible side effects of intranasal MF, sinusitis, epistaxis, and infection.